Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

THOMAS E WITZIG

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1508846791
CMS profile
68170
Location
ROCHESTER, MN

General Payments · PY2018–2024

$66,306.73

  • Reported across 64 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$17,381.59

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $10,433.27 7
Consulting Fee $6,750.00 1
Food and Beverage $198.32 7

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genmab U.S., Inc. $17,381.59 15

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $12,747.64 18
PY2019 $19,016.86 21
PY2020 $4,582.50 3
PY2021 $2,895.00 2
PY2022 $9,548.14 4
PY2023 $135.00 1
PY2024 $17,381.59 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Genmab U.S., Inc. $8,968.40 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1126832905 CMS
Genmab U.S., Inc. $10.67 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1126832897 CMS
Genmab U.S., Inc. $5.85 04/12/2024 Food and Beverage Undisputed 01/23/2026 1126832903 CMS
Genmab U.S., Inc. $280.00 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1126832913 CMS
Genmab U.S., Inc. $54.33 04/12/2024 Food and Beverage Undisputed 01/23/2026 1126832919 CMS
Genmab U.S., Inc. $7.98 04/13/2024 Food and Beverage Undisputed 01/23/2026 1126832907 CMS
Genmab U.S., Inc. $29.34 04/13/2024 Food and Beverage Undisputed 01/23/2026 1126832909 CMS
Genmab U.S., Inc. $704.58 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1126832911 CMS
Genmab U.S., Inc. $64.91 04/13/2024 Food and Beverage Undisputed 01/23/2026 1126832917 CMS
Genmab U.S., Inc. $18.62 04/13/2024 Food and Beverage Undisputed 01/23/2026 1126832921 CMS
Genmab U.S., Inc. $17.29 04/13/2024 Food and Beverage Undisputed 01/23/2026 1126832925 CMS
Genmab U.S., Inc. $280.00 04/14/2024 Travel and Lodging Undisputed 01/23/2026 1126832901 CMS
Genmab U.S., Inc. $78.00 04/14/2024 Travel and Lodging Undisputed 01/23/2026 1126832915 CMS
Genmab U.S., Inc. $111.62 04/14/2024 Travel and Lodging Undisputed 01/23/2026 1126832923 CMS
Genmab U.S., Inc. $6,750.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 1126832899 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.